Skip to content

Early complications after supracapsular versus dual-mobility hip arthroplasty

Early complications of Percutaneous-assisted Supracapsular Uncemented Total Hip Arthroplasty versus posterior-approach Uncemented Dual-Mobility Arthroplasty for the treatment of Displaced Femoral Neck Fractures: a prospective randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9hg5csq
Enrollment
48
Registered
2026-07-08
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral neck fractures Femoral Fractures

Interventions

This is a prospective randomized clinical trial comparing the early complications of two techniques: conventional uncemented total hip arthroplasty by posterior approach and percutaneously assisted su

Sponsors

Faculdade de Ciências Médicas da Santa Casa de Misericórdia de São Paulo - FCMSCMSP
Lead Sponsor
Irmandade da Santa Casa de Misericórdia de São Paulo
Collaborator

Eligibility

Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 65 years; American Society of Anesthesiologistsysical status I, II, or III; patients with displaced femoral neck fractures; patients admitted to the study hospital

Exclusion criteria

Exclusion criteria: Patients with pathological femoral neck fractures; previous neurological sequelae affecting the involved side

Design outcomes

Primary

MeasureTime frame
Stability observed after total hip arthroplasty up to 90 days post-operatively.

Secondary

MeasureTime frame
Differences between the groups are expected regarding estimated blood loss, quantified in milliliters (mL); the rate of intraoperative fractures; the rate of neurological injuries related to the surgical procedure; the time to ambulation, quantified in hours; and the rate of surgical site infection

Countries

BR

Contacts

Public ContactSantiago Arcentales

Irmandade da Santa Casa de Misericórdia de São Paulo

santiago_a.p@hotmail.com+55(11)99704-2681

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026